Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kerkhof (Singapore, Singapore), J. Voorham (Singapore, Singapore), C. Cabrera (Mölndal, Sweden), P. Darken (Morristown, NJ, United States of America), P. Dorinsky (Durham, NC, United States of America), J. Kocks (Singapore, Singapore), M. Sadatsafavi (Vancouver, BC, Canada), D. Sin (Vancouver, BC, Canada), D. Price (Singapore, Singapore). Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker. 2154

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Associations between blood eosinophils and decline in lung function among adults with and without asthma Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017 Year: 2018 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002